In this article, we will look at the 11 Best Large Cap Value Stocks to Buy Now.
On September 26, Jeremy Siegel, Wharton professor emeritus and WisdomTree senior economist, appeared on CNBC’s ‘Closing Bell’ to talk about the latest PCE report, whether the Fed should deemphasize inflation, and more.
The week’s econ data, according to CNBC, showed that jobless claims were the lowest since mid-July, Q2 GDP experienced the highest growth since Q3 2023, and the August durable goods crushed estimates. In addition, the PCE prices were in line with expectations.
READ ALSO: Stocks On The Rise: 12 Best Stocks to Invest in Right Now and 12 Affordable Biotech Stocks to Invest In Now.
Siegel stated that all forecasters have now raised their GDP estimates for Q3. With tame inflation and stronger real growth, he considers all these factors to be good signs for the stock market.
While he does expect the tariffs to cause a bump in inflation, he also thinks that the Fed has to look beyond that, primarily because tariffs are like a tax, and that is not a sign of too much demand for goods in the economy. According to him, that is what the Fed has to look out for.
With these trends in view, let’s look at the best large cap value stocks to buy now.
Our Methodology
We used stock screeners to make a list of value stocks with a market cap between $10 billion and $200 billion and a forward P/E below 15. We then selected the top 11 stocks with the highest number of hedge fund holders as of Q2 2025, sourcing the hedge fund sentiment data from Insider Monkey’s database. The list is sorted in ascending order of hedge fund holders.
Note: All data was sourced on September 28.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).
11 Best Large Cap Value Stocks to Buy Now
11. Chubb Limited (NYSE:CB)
Forward P/E: 12.96
Market Cap: $111.91 billion
Number of Hedge Fund Holders: 61
Chubb Limited (NYSE:CB) is one of the best large cap value stocks to buy now. On September 19, Raymond James analyst Gregory Peters reiterated a Buy rating on Chubb Limited (NYSE:CB) and set a price target of $340.00.
Chubb Limited (NYSE:CB) reported a net income of $2.97 billion in its fiscal Q2 2025 results, up 33.1%. Core operating income for the quarter reached a record $2.48 billion, up 12.9%.
Management also reported that the P&C net premiums written for the quarter were $12.39 billion, up 5.2%, or 5.8% in constant dollars.
Chubb Limited (NYSE:CB) provides commercial and personal property and casualty insurance, personal accident and health (A&H), life insurance, and more.
The company’s operations are divided into the following segments: North America Commercial Property and Casualty (P&C) Insurance, North America Personal P&C Insurance, North America Agricultural Insurance, Overseas General Insurance, Global Reinsurance, and Life Insurance.
10. Amgen Inc. (NASDAQ:AMGN)
Forward P/E: 12.95
Market Cap: $146.96 billion
Number of Hedge Fund Holders: 62
Amgen Inc. (NASDAQ:AMGN) is one of the best large cap value stocks to buy now. On September 26, Bank of America Securities analyst Tim Anderson maintained a Sell rating on Amgen Inc. (NASDAQ:AMGN) and set a price target of $272.00.
The same day, Amgen Inc. (NASDAQ:AMGN) announced a $650 million expansion of its U.S. manufacturing network, creating hundreds of new jobs.
Management reported that the planned investment is anticipated to create around 750 jobs, and would support increased drug production at its biologics manufacturing facility in Juncos along with integrating “innovative advanced technologies throughout the operations process”.
Amgen Inc. (NASDAQ:AMGN) is a biotechnology company that discovers, develops, manufactures, and markets human therapeutics. It delivers new therapies for patients with complex cancers, especially in areas with significant unmet needs.
